Generate a tailored SOP for Dr. Daniel Lévesque. Improve your application with a focused, well-structured draft.
Daniel Lévesque is a full professor at the Faculty of Pharmacy of the Université de Montréal. His research focuses on the discovery and validation of therapeutic targets and pharmacotherapy in the central nervous system. Specifically, his work on Parkinson's disease examines designing highly selective modulators of the Nur77/RXR nuclear receptor complex, a promising pharmacological target for involuntary movement disorders, such as dyskinesia caused by levodopa. He has supervised numerous master's and doctoral theses, contributing to advancing knowledge in pharmacological and molecular characterization of tardive dyskinesias and related disorders. His research projects include identifying lead compounds that modulate Nur77/RXR receptor activity and exploring neural mechanisms underlying psychostimulant drug effects. Through his research, Lévesque aims to develop innovative therapeutic strategies for neurodegenerative diseases, emphasizing his ongoing commitment to advancing pharmacotherapy in the context of these complex conditions.
Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.